Skip to content
DefDex

Federal award

ROCHE DIAGNOSTICS CORPORATION

W81K0018P0655

Contract

Obligated and Ceiling

Obligated (net)
$4,260,900.00
Ceiling (potential value, not spending)
$7,625,850.00
Current value
$7,625,850.00
Gross positive obligations
$4,260,900.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
ROCHE DIAGNOSTICS CORPORATION · JDMDFEZBYH36
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
GENMARK DIAGNOSTICS INC. · ZKZ6C6X3XLD3
Awarding agency
Department of War · sub-agency 2100 · office W81K00
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W81K0018P0655
Award type code
B
Actions
14 · Sep 27, 2018 to Sep 7, 2023
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History14

Award actions
DateFYModAction typeObligationCompany in company totals
Sep 7, 2023FY2023P00013M$0.00
—
Jul 28, 2023FY2023P00012M$0.00
—
Nov 1, 2022FY2023P00011C$2,130,450.00
—
Jun 28, 2022FY2022P00010G$0.00
—
Nov 18, 2021FY2022P00009C$2,130,450.00
—
Aug 12, 2021FY2021P00008G$0.00
—
Oct 20, 2020FY2021P00007M$0.00
—
Oct 15, 2020FY2021P00006A$0.00
—
Aug 30, 2020FY2020P00005G$0.00
—
Nov 12, 2019FY2020P00004C$0.00
—
Sep 12, 2019FY2019P00003M$0.00
—
Aug 21, 2019FY2019P00002G$0.00
—
Oct 1, 2018FY2019P00001C$0.00
—
Sep 27, 2018FY20180—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.